The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Nuclear morphology is a deep learning biomarker of cellular senescence
Open accessPublished version of a preprint
Abstract
Cellular senescence is an important factor in aging and many age-related diseases, but understanding its role in health is challenging due to the lack of exclusive or universal markers. Using neural networks, we predict senescence from the nuclear morphology of human fibroblasts with up to 95% accuracy, and investigate murine astrocytes, murine neurons, and fibroblasts with premature aging in culture. After generalizing our approach, the predictor recognizes higher rates of senescence in p21-positive and ethynyl-2’-deoxyuridine (EdU)-negative nuclei in tissues and shows an increasing rate of senescent cells with age in H&E-stained murine liver tissue and human dermal biopsies. Evaluating medical records reveals that higher rates of senescent cells correspond to decreased rates of malignant neoplasms and increased rates of osteoporosis, osteoarthritis, hypertension and cerebral infarction. In sum, we show that morphological alterations of the nucleus can serve as a deep learning predictor of senescence that is applicable across tissues and species and is associated with health outcomes in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although it remains unclear whether cancer cell senescence is irreversible, primary cancer therapeutics that trigger a senescence-like phenotype in cancer cells allow further targeting of these cells using a one-two-punch approach (senescence-senolysis) to eliminate surviving cancer cells148,149.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [149]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“is characterized by morphological and functional changes, including enlarged cell size,9,10 nuclear changes,11,12,13,14,15 metabolic remodeling,16 and the SASP.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Deep learning methods have been recently developed to detect senescent cells in culture with phase-contrast imaging99 and tissues with H&E and DAPI staining65.”
From Spatial mapping of cellular senescence: emerging challenges and opportunities (2023) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“This approach using deep learning for the identification of senescent cells was originally developed with human fibroblasts in cell culture, but, using image transformation to focus on nuclear morphology, these deep learning models were applied to diverse cell types in culture and tissues (Fig. 6a).”
From Spatial mapping of cellular senescence: emerging challenges and opportunities (2023) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, p21CIP1-positive nuclei exhibited higher predicted levels of senescence in multiple tissues, while proliferating cells (indicated by 5-ethynyl-2′-deoxyuridine (EdU) incorporation) showed lower levels65.”
From Spatial mapping of cellular senescence: emerging challenges and opportunities (2023) · cites this paper as [65]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U-Net: Convolutional Networks for Biomedical Image Segmentation
Ronneberger, O., Fischer, P., & Brox, T. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-24574-4_28 · Cited by 99,404
Dropout as a bayesian approximation: Representing model uncertainty in deep learning
Gal, Y., & Ghahramani, Z. (2015) · arXiv · doi:10.48550/arxiv.1506.02142 · Cited by 6,471
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“There is considerable overlap between molecular factors that associate with senescence, DNA damage, inflammation and other processes 8,9 , and no single marker reliably and consistently identifies senescence 10–12 .”
BackgroundCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 1×
“We also found several other conditions associated with senescence 48 , including osteoporosis 49 , osteoarthritis 50 , hypertension 51 , cerebral infarction 52 , hyperlipidemia, hypercholesteremia, dyspnea and sciatica.”
BackgroundHallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605 · cited 1×
“31,32 ).”
Senescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 2×
“This finding is consistent with the notion that senescence is a mechanism to control cancer development by limiting uncontrolled proliferation 18 .”
BackgroundResultDebacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348 · cited 1×
“Senescent cells present a complex and diverse phenotype, which varies substantially by cell type and source 6,7 .”
BackgroundSenescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Cited by
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 498
“Robust validation and responsible data curation will facilitate biomarker identification and application, supporting future drug development and disease treatment.”
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“It is not yet clear how these methods will perform in detecting senescent cells in different tissues, although encouraging results indicate they are applicable in tissues 279 .”
InfluentialGuidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Xu, F. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02096-7 · Cited by 259
“…large nuclei, lobulated, enlarged/fragmented nucleolus, Nucleocytoplasmic trafficking ↓ , Senescence-associated heterochromatin foci (SAHF) [57–59] nc866 ↓ [60] Lamin-B1 ↓ [61] Nuclear transcription factors TFEB/TEB3 ↑ [62] Secretory factors Production of SASP: contains cytokines, chemokines,…”
Senescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
“Several efforts are aiming to better identify SnCs, for example by using machine learning classifiers based on trans-criptome profiles 180 or imaging data of SnCs 185–187 .”
Metadata
- Authors
- Heckenbach, I., Mkrtchyan, G. V., Ezra, M. B., Bakula, D., Madsen, J. S., Nielsen, M. H., Oró, D., Osborne, B., Covarrubias, A. J., Idda, M. L., Gorospe, M., Mortensen, L., Verdin, E., Westendorp, R., & Scheibye-Knudsen, M.
- Affiliations
- University of Copenhagen (DK)
- Gubra (Denmark) (DK)
- University of California, Los Angeles (US)
- Institute of Genetic and Biomedical Research (IT)
- National Institute on Aging (US)
- Buck Institute for Research on Aging (US)
- ORCID
- Venue
- Nature Aging
- Published
- 2022-08-15
- Volume
- 2
- Issue
- 8
- Pages
- 742-755
- ISSN
- 2662-8465 (ISSN-L)
- PMC
- PMC10154217
- OpenAlex
- W4291793058
- Cited by
- 232
- References
- 55
- Citations by year
- 2026: 59 · 2025: 63 · 2024: 67 · 2023: 36 · 2022: 6
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Aging (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination (U54 AG075932)
- Novo Nordisk Fonden (NNF17OC0027812)
- Lundbeckfonden (R324-2019-1492)
- Ministry of Higher Education and Science | Forskerakademiet (0238-00003B)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
- Keywords
- cellular senescence, nuclear morphology, human fibroblasts, astrocytes, neurons, premature aging, p21, senescent cells, aging, age-related diseases, osteoporosis, osteoarthritis, hypertension, cerebral infarction, cancer risk, liver tissue
- MeSH terms
- Deep Learning, Aging, Animals, Humans, Biomarkers, Cellular Senescence, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nuclear morphology is a deep learning biomarker of cellular senescence. https://app.cochat.ai/papers/10.1038/s43587-022-00263-3
- The paper
- Heckenbach, I., Mkrtchyan, G. V., Ezra, M. B., Bakula, D., Madsen, J. S., Nielsen, M. H., Oró, D., Osborne, B., Covarrubias, A. J., Idda, M. L., Gorospe, M., Mortensen, L., Verdin, E., Westendorp, R., & Scheibye-Knudsen, M. (2022). Nuclear morphology is a deep learning biomarker of cellular senescence. Nature Aging. https://doi.org/10.1038/s43587-022-00263-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.